Home Study Details

    Program Type

    Home Study Webcast


    1.25 Contact Hour(s)

    Release Date

    Monday, April 20, 2020

    Offline Date

    Thursday, April 20, 2023

    ACPE Expiration Date

    Thursday, April 20, 2023

    Target Audience




    • Overview

      Challenge accepted. Our country has made numerous strides in advancing patient care, and, more particularly, in increasing efforts to ensure that lives within the national opioid crisis are saved and/or improved. One of those positive strides involves the FDA approval of abuse-deterrent formulation (ADF) opioid medications, with the aim of preventing the transition from the misuse and/or abuse of prescription opioid medications to illicit (and possibly laced) diacetylmorphine (a.k.a. heroin). One may ask:

      How do these formulations work?

      What abuse-deterrent formulation (ADF) opioid medications are not only available on the U.S. market, but also specifically approved as an ADF opioid medication?

      Are these abuse-deterrent formulations really fool-proof?

      Well, the street chemists of our country have already accepted the challenge to be knowledgeable on all of the above, so now it’s our turn as healthcare professionals to get up-to-speed on these risk-reduction entities. So please join us for this discussion as part of the overall Substances of Abuse Specialty Pharmacist (SASP) certificate training program.


      • Slide Document :   20068_H04_2pp.pdf
      • Slide Document :   20068_H04_6pp.pdf

      Financial Support By

    • Pharmacist

      Identify the seven current types of abuse-deterrent formulations.
      Discuss common methods of manipulation of abuse-deterrent formulation (ADF) opioid medications.
      Recall all of the available abuse-deterrent formulation (ADF) opioid medications, with particular attention to the select few that are both FDA approved specifically as ADF opioid medications and available on the U.S. market.
    • Activity Type


      CE Broker


      Universal Activity Number

      Pharmacist 0798-0000-20-068-H04-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones

    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Firefox 3.0.3 or higher

    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).